Osteoarthritis. Arthrosis
Conditions
Interventions
Intervention 1: Experimental group: 20% Dextrose solution + 2% lidocain, 3 Injections monthly. Intervention 2: Control group: Methylprednisolon Acetate solution, 40mg + Lidocain 2%, 1 Injecton.
Treatment - Drugs
Experimental group: 20% Dextrose solution + 2% lidocain, 3 Injections monthly
Control group: Methylprednisolon Acetate solution, 40mg + Lidocain 2%, 1 Injecton
Sponsors
Research group of 501 army university
Eligibility
Sex/Gender
All
Age
40 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion:1-Age>40 2-First carpometacarpal joint pain over 3/10 on VAS scale with symptoms present greater than 3 months 3-Confirmation of CMC osteoarthritis with radiography 4-The Gripping disorder in functional assessment scores 5-Ability to make follow up visits over the 6-month protocol. Exclusion:1-Recent trauma to the hand or fractures seen on radiographs 2-History of joint inflammatory or infectious disorder 3-Allergies to injected solutions 4-CMC joint injections in the prior 6 months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before injection and 1, 2 and 6 months after the last injection. Method of measurement: VAS scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hand function and pinch grip strength. Timepoint: Before injection and 1, 2 and 6 months after the last injection. Method of measurement: HAQ-I scale and Pinch guage. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact?Dr Azadeh Jahangiri
501 Hospital
Outcome results
None listed